Logerfo Michael
Chief Legal Officer at Sagent Pharmaceuticals, Inc.
- Sold, on record
- $619k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Feb 27, 2014
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Sagent Pharmaceuticals, Inc.Chief Legal Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Sagent Pharmaceuticals, Inc.UnusualMay 25, 2012 2012
Sold 7,000 shares at $15.86 ($111k)
Logerfo Michael, Chief Legal Officer
Sold 34% of holdings ($327k position)13,615 shares leftFirst sale on recordFiling
- 2 Form 4 sale Sagent Pharmaceuticals, Inc.UnusualNov 15, 2012 +174 days
Sold 10,000 shares at $14.40 ($144k)
Logerfo Michael, Chief Legal Officer
Sold 30.5% of holdings ($472k position)22,753 shares leftFiling
- 3 Form 4 sale Sagent Pharmaceuticals, Inc.UnusualNov 19, 2012 +4 days
Sold 9,138 shares at $14.65 ($134k)
Logerfo Michael, Chief Legal Officer
Sold 40.2% of holdings ($333k position)13,615 shares leftFiling
- 4 Form 4 sale Sagent Pharmaceuticals, Inc.Plan not statedFeb 20, 2014 +458 days
Sold 8,532 shares at $21.93 ($187k)
Logerfo Michael, Chief Legal Officer
Sold 19.1% of holdings ($978k position)36,063 shares left0.9x usual sizeFiling
- 5 Form 4 sale Sagent Pharmaceuticals, Inc.Plan not statedFeb 27, 2014 +7 days
Sold 2,021 shares at $21.43 ($43k)
Logerfo Michael, Chief Legal Officer
Sold 5.8% of holdings ($751k position)33,011 shares left0.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2014 | Feb 28, 2014 | Sagent Pharmaceuticals, Inc. | Chief Legal Officer | Form 4 sale | 2,021 | $43k | 5.8% | Plan not stated | SEC |
| Feb 20, 2014 | Feb 24, 2014 | Sagent Pharmaceuticals, Inc. | Chief Legal Officer | Form 4 sale | 8,532 | $187k | 19.1% | Plan not stated | SEC |
| Nov 19, 2012 | Nov 20, 2012 | Sagent Pharmaceuticals, Inc. | Chief Legal Officer | Form 4 sale | 9,138 | $134k | 40.2% | Unusual | SEC |
| Nov 15, 2012 | Nov 16, 2012 | Sagent Pharmaceuticals, Inc. | Chief Legal Officer | Form 4 sale | 10,000 | $144k | 30.5% | Unusual | SEC |
| May 25, 2012 | May 29, 2012 | Sagent Pharmaceuticals, Inc. | Chief Legal Officer | Form 4 sale | 7,000 | $111k | 34.0% | Unusual | SEC |